NEW YORK, NY / ACCESSWIRE / November 24, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT)'s sale to Indivior PLC. Per the agreement, Indivior would acquire Opiant for $20.00 per share in cash, plus up to $8.00 per share in contingent value rights that may become payable in the event that certain net revenue milestones are achieved during the relevant seven-year period by OPNT003 after its approval and launch.If you are an Opiant shareholder, click here to learn more about your rights and options.
Elevate Credit, Inc. (NYSE: ELVT)'s sale to an affiliate of Park Cities Asset Management LLC for $1.87 per share.If you are an Elevate Credit shareholder, click here to learn more about your rights and options.
Imago BioSciences, Inc. (NASDAQ: IMGO)'s sale to Merck for $36.00 per share in cash. If you are an Imago shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE: Halper Sadeh LLC